Seroconversion of GAD antibody in "unclassified" diabetes with long duration of disease [2]

Diabetes Care

Volumn 27, Issue 7, 2004, Pages 1836-1837

  Shigihara, Toshikatsu ^a   Shimada, Akira ^a   Saisho, Yoshihumi ^a   Kawai, Toshihide ^a   Maruyama, Hiroshi ^b   Saruta, Takao ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Otolaryngology   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUFORMIN; GLIBENCLAMIDE; GLUTAMATE DECARBOXYLASE ANTIBODY; PANCREAS ISLET CELL ANTIBODY; VOGLIBOSE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HLA TYPING; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; LATENT AUTOIMMUNE DIABETES IN ADULTS; LETTER; ONSET AGE; RELIABILITY; SEROCONVERSION; SERUM;

EID: 3042834388     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.7.1836-a     Document Type: Letter

References (3)

1. Zimmet PZ, Toumi T, Mackay R, Rowley MJ, Knowles W, Cohen M, Lang DA: Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299-303, 1994
2. Kobayashi T, Itoh T, Kosaka K, Sato K, Tsuji K: Time course of islet cell antibodies and β-cell function in non-insulin-dependent stage of type 1 diabetes. Diabetes 36:510-517, 1987
3. Landin-Olsson M, Amqvist H, Blohme G, Littorin B, Lithner F, Nystrom L, Schersten B, Sundkvist G, Wibell L, Ostman J, Lemmark A: Appearance of islet cell autoantibodies after clinical diagnosis of diabetes mellitus. Autoimmunity 29:57-63, 1999